twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2022
vol. 124
 
Share:
Share:
abstract:
Review paper

Focal therapies for retinoblastoma

Krzysztof Cieślik
1
,
Anna Rogowska
1
,
Wojciech Hautz
1

  1. Klinika Okulistyki Instytutu „Pomnik – Centrum Zdrowia Dziecka” w Warszawie
    Department of Ophthalmology, Children’s Memorial Health Institute in Warsaw, Poland
KLINIKA OCZNA 2022, 124, 3:131-136
Online publish date: 2022/03/31
View full text Get citation
 
PlumX metrics:
Currently, the primary treatment for retinoblastoma is intravenous and/or intraarterial chemotherapy. However, adjuvant focal therapies are also an essential component in the treatment of this cancer. The article discusses the methods of focal treatment of retinoblastoma: cryotherapy, transpupillary laser thermotherapy, transpupillary laser thermotherapy with intravenous indocyanine, brachytherapy, enucleation, and intraarterial and bicameral injections of melphalan. Particular attention is given to the latest methods of treatment including topical chemotherapy (intravitreal injections) and intraarterial chemotherapy. These modern topical treatments help salvage the eye in an increasing number of patients with advanced retinoblastoma.
keywords:

retinoblastoma, thermotherapy, cryotherapy, melphalan, brachytherapy

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.